INTRODUCTION Blood transfusion plays significant roles in the obstetrics. Obstetric haemorrhage is one of the leading causes of maternal morbidity and mortality in developing countries (WHO, Owonikoko et al, 2014). Globally, it has been reported that annually, obstetric hemorrhage is the common cause of estimated one hundred and twenty seven thousand maternal deaths. Furthermore, massive and deadly obstetric hemorrhage occurs in 3 to 5% of deliveries and in 0.3 to 1% of the deliveries, transfusion of blood
a child refusing blood transfusions that are necessary to save the child’s life. This paper will examine the ethical dilemma in pediatric nursing of a parent’s refusal of blood products for their child; apply relevant principles from the ANA Code of Ethics, and analyze possible resources used for resolution and dilemma outcomes. Ethical Dilemma One ethical dilemma that may be encountered in the field of pediatrics is the parents of a child refusing necessary blood transfusions for their
characteristics of a Jehovah’s witness faith is they refuse blood products on the grounds that it is doctrinally forbidden, regardless of the possibility of death. This Christian sect has developed a position for blood transfusions through the analysis of Genesis 9 and Leviticus 17 to “not eat from the bread of life”. God views blood as embodying life so they avoid taking blood out of respect to God. Some Jehovah’s witnesses believe receiving blood products could lead to expulsion from their community
line. It is known as a secondary lymphoid organ and the largest organ involved in lymphatics1.It is made up of two parts: white pulp which is responsible for the maturation of lymphatic cells as well as blood cells; and the red pulp which is responsible for filtration and the removal of old blood cells2. THE SPLEEN HAS THREE MAIN ACTIONS3: 1. Sequestration: The reticular meshwork of the cords in the red pulp trap cells by creating adhesion to them and then filter out the senescent or poorly formed
as enablers and barriers to their motivation in donating blood at present or in the future. The enablers in the list include: (1) family, friends and relatives; (2) health status; (3) knowledge on blood donation; (4) their known benefits on donating blood and (4) others while the barriers in the list include: (1) family, friends and relatives; (2) health status; (3) knowledge on blood donation; (4) their known disadvantages on donating blood and (4) others. These enablers and barriers are chosen
pediatric hematologist-oncology, and transfusion medicine. A hematology pathologist is a doctor who specializes in the diagnosing blood disorders. Hematologist focuses on diagnosing and treating the blood disorders and an oncologist focuses on cancer. The primary care provider(PCP) prevents, diagnoses, and treats diseases. A pediatric hematology-oncologist treats blood disorders and cancer in children and transfusion medicine manages the transfusion of blood products and potential complications.
Lyme disease or Lyme Borreliosis is a serious infectious disease that is reported in many countries in the world. In 2013, the disease is claimed to be the fastest growing infectious disease in the United States with more than 300,000 cases reported from forty-nine states (CDC). This disease also afflicts 65,000 Europeans each year. Recent years’ reports show that there has been an dramatically increase in the number or Lyme disease incidences in both the United States and Europe (CDC, Pearson 88)
response. Blood is a complex fluid made up of fluid portion called as plasma and cellular elements like RBC, WBC and Platelets. The WBC or leucocytes
and Social Care, and approved Access course (NHS Career,2015b). A radiography course consists of one year studying scientific contents such as physiology and radiation science; this will be followed by further trainings in oncology, psycho-social studies and extensive modules (NHS Career,2015c). According to Society of Radiographers (2015), it is important to be registered with the Health
cell for the purpose of either correcting a genetic problem or giving a cell a new biological function. The purpose of gene therapy is to correct an undesirable trait or disease by introducing a modified copy of a gene into a target cell. In most cases, the purpose is not to replace a defective gene in the host cell but rather to provide a new copy so that the correct protein can be expressed and the detrimental effects of the defective gene neutralized (). This “therapy’ is a fairly new practice